Related Experiment Video

Updated: May 29, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

Update of respiratory tract disease in children with primary ciliary dyskinesia

Scott D Sagel1, Stephanie D Davis, Paolo Campisi

  • 1Children's Hospital Colorado, Aurora, CO 80045, USA. sagel.scott@tchden.org

Proceedings of the American Thoracic Society
|September 20, 2011
PubMed

Insights

Primary ciliary dyskinesia (PCD) causes chronic sinopulmonary disease due to impaired mucociliary clearance. This review highlights challenges in pediatric PCD diagnosis and treatment, emphasizing the need for validated outcome measures for future clinical trials.

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Rare Diseases

Background:

  • Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting ciliary function.
  • It leads to impaired mucociliary clearance and progressive sinopulmonary disease.
  • Respiratory tract issues are hallmark manifestations of PCD.

Purpose of the Study:

  • To review current knowledge on respiratory tract disease in PCD patients.
  • To identify challenges in diagnosing and quantifying lung disease in young children with PCD.
  • To recommend clinical endpoints and outcome measures for PCD research.

Main Methods:

  • Literature review of existing research on PCD.
  • Analysis of challenges in pediatric PCD diagnosis and outcome assessment.
  • Synthesis of recommendations for clinical trial endpoints and therapeutic targets.

Main Results:

  • PCD diagnosis and lung disease quantification in young children present significant challenges.
  • Current PCD treatments are not evidence-based and often extrapolated from other conditions.
  • There is a critical need for validated outcome measures, including patient-reported outcomes.

Conclusions:

  • Developing and validating outcome measures is crucial for evaluating new PCD therapies.
  • Recommendations are provided for clinical endpoints and outcome measures.
  • A prioritized list of treatments for future PCD clinical trials is proposed.

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

In vivo Evaluation of Mucociliary Clearance in Mice06:35

In vivo Evaluation of Mucociliary Clearance in Mice

Published on: December 18, 2020

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Physical Assessment of the Respiratory Tract I: Health History01:28

Physical Assessment of the Respiratory Tract I: Health History

Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and key...